Foundational guide
NAD+ Near Me: Ask Which Grade Is Going in the Bag
This is one of the few compounds on this site where a local search returns the right answer. What it returns is a service rather than a product, and four questions asked at the desk establish more about it than any amount of comparing websites.
A search for NAD+ near me returns clinics, and for once that is the correct result. Most compounds covered on this site have no local channel at all, so the honest answer to the equivalent query is that nothing local exists. This one is different: infusion clinics, wellness practices and med spas advertise NAD+ openly, by name, in most metropolitan markets.
What they are selling is a service, and the interesting questions are all upstream of the building you would walk into. NAD+ is a coenzyme supplied in bulk, and the bulk material reaches a clinic bag through a chain that FDA has publicly said is going wrong.
The mail-order alternative that the last section compares against:
Supplier publishing lot-level data
NAD+, Ascension Peptides
Every lot carries certificates from two independent laboratories. The code below halves the listed price on the vial.
Quoted per 100 mg because NAD+ is dosed in hundreds of milligrams, not the single milligrams a peptide vial holds. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price. Free shipping starts at $250.
- Kovera Labs and MZ Biolabs certificates per lot
- Carriage free above $250
- Dispatched same day before 2pm CST
Supplied for laboratory research use and not for human consumption. Affiliate links: a commission may be earned at no cost to the reader, and it does not affect the assessment above. Prices verified August 20, 2026.
NAD+ near me returns a service, not a product
The distinction that organises everything else is between the provider and the compounder. The provider is who you book with. The compounder is who made the preparation, and in most cases they are not the same organisation.
| Provider type | Who prepares the product | What is knowable if you ask |
|---|---|---|
| Physician practice or infusion centre | A compounding pharmacy working to a prescription, or a registered outsourcing facility supplying the practice | The compounder's name, the lot, and whether a certificate of analysis for the starting material exists and includes endotoxin testing |
| Med spa or wellness clinic | Usually an external compounder, with a supervising clinician arrangement that varies by state | The same three facts, though the front desk is less likely to hold them and may need to ask |
| Mobile or at-home service | An external compounder, with the preparation transported before administration | The same three facts plus one more: how the preparation was stored and carried between the pharmacy and your address |
FDA is explicit on the general point that compounded drugs are not FDA-approved, which means the agency has not reviewed them for safety, effectiveness or quality before they are dispensed. That is not an accusation against any provider. It is the accurate description of the object, and it is why the questions below are reasonable rather than adversarial.
Four questions for the desk
Each of these takes a sentence to ask and has an answer that either exists or does not. None of them require any technical vocabulary beyond the words themselves.
| Question | Answer that holds up | Answer that ends the conversation |
|---|---|---|
| Who compounded this preparation? | A named pharmacy or a named outsourcing facility, offered without hesitation | Our supplier, or a refusal to name them, which means nobody outside the room can be checked |
| Was the starting material pharmaceutical grade or food grade? | Pharmaceutical grade, with a willingness to show where that is stated | Confusion about the distinction, or an assurance that all NAD+ is the same |
| Does the certificate of analysis report bacterial endotoxins? | Yes, with a result in endotoxin units, and the document available on request | A purity percentage offered instead, which answers a different question entirely |
| What is the lot number of what I am receiving? | A specific number, recorded in your chart | No lot is tracked, which means nothing can be traced afterwards if you react badly |
The third question is the one that carries the weight, and it is worth knowing why before asking it. Purity and endotoxin are unrelated measurements. Endotoxins are lipopolysaccharide fragments from the walls of Gram-negative bacteria; they are heat stable, they pass through the filters that remove viable organisms, and they are active at quantities far too small to register as an impurity peak. A high purity figure is entirely compatible with a pyrogenic preparation. Only a bacterial endotoxins test addresses it, and the full argument is on our injectable formats page.
Why FDA's notice is a local question
It is easy to read a regulatory notice as being about industry rather than about a Tuesday afternoon appointment. This one is not.
In a notice whose content is current as of October 2024, FDA reminded compounders to use ingredients suitable for sterile compounding. It stated that it is aware of compounders using food-grade nicotinamide adenine dinucleotide sold by repackagers to make intravenous products, and that ingredients identified as food grade are not suitable for compounding sterile drugs without appropriate processing, due to the high risk of contamination with microbes and endotoxins. It then reported adverse event reports following use of NAD+ injectable drugs, including severe chills, shaking, vomiting and fatigue, with some requiring medical treatment, and said these reactions are consistent with excessive levels of endotoxins.
Read the symptom list again with a chair in mind. Those are things that happened to people receiving an infusion, and the cause was decided two steps upstream by a purchasing decision at a compounder. That is what makes the four questions above a local matter rather than a technicality: the provider is the only party in the chain you have direct contact with, and the questions are the only mechanism you have for reaching past them.
One structural fact helps. Outsourcing facilities register with FDA and appear on a published list, so if a provider names one, the name can be checked in a browser. That is a rare thing in this market: a claim with a public register behind it.
What the session price includes, without inventing a number
We are not going to publish a clinic price range. Session pricing varies by market and practice, it is published inconsistently, and a figure assembled from impression would be the least defensible thing on a page whose argument is that unsupported figures deserve distrust. The structure can be described exactly, and the structure is what usually surprises people.
- Sessions are priced individually and then discounted into multi-visit packages or memberships, so a headline figure and an effective figure diverge.
- The price bundles the compounded preparation, the giving set and consumables, the room and chair time, and the clinician. None of those is itemised.
- The quantity of NAD+ in the preparation is rarely stated on a price list, which means the division that would produce a cost per 100 mg cannot be performed from published information.
- The comparison that can be made is qualitative: a session buys administration and accountability, and a research-supply order buys a labelled quantity of material and a certificate. The checkable vial arithmetic is on our price page.
What is marketed locally and what is established
Local pages for this compound tend to carry a long list of conditions. This site reports that clinics market NAD+ infusions for a range of indications and does not repeat the list as claims, because repeating a marketing claim in order to describe it is how the claim spreads.
What is genuinely established is the biochemistry. NAD+ is the coenzyme carrying electrons through central energy metabolism and the substrate consumed by sirtuins, PARPs and related enzymes, and its cellular roles are reviewed thoroughly by Covarrubias and colleagues. That literature is overwhelmingly cell and animal work. It supports the statement that NAD+ matters in metabolism. It does not support the statement that infusing it changes a clinical outcome.
The most directly relevant published human work is a pilot study by Grant and colleagues that measured plasma and urine NAD+ metabolites during and after a six-hour intravenous infusion in a small cohort. It is uncontrolled and pharmacokinetic in design: it describes where infused material goes, not whether anyone got better. A clinic that cites it is citing something real, and it is not evidence of benefit.
The mail-order route, and what it does not replace
The alternative to a local provider is research-supply material bought by the gram, and it is a genuinely different transaction rather than a cheaper version of the same one.
What it gains is verification. The lot certificate can be requested and read before any money moves, the endotoxin line can be looked for specifically, and the cost is a published figure you can divide yourself. What it loses is everything the clinic supplies: a sterile compounded preparation, an administration performed by someone trained to perform it, and a professional who is accountable if something goes wrong. Research material is not a sterile drug product, is not released as one, and no regulator has assessed any batch of it.
So this page does not end by recommending one over the other, because they answer different questions. It ends with the observation that the same four questions apply to both, and that only one of the two channels lets you ask them before paying. The routes are compared on friction in how to get NAD+, channel by channel in where to buy NAD+, and the legal position of each is set out in NAD+ without prescription. Nothing on this page describes or implies human use.
Frequently asked questions
- What does a NAD+ clinic near me actually sell?
- A service rather than a product. You are buying an administered session, which bundles a sterile compounded preparation, the consumable set, the chair time and a clinician who is accountable for the administration. The preparation itself has usually come from a compounding pharmacy or a registered outsourcing facility rather than being made on site. That means the questions worth asking are about the supply chain behind the bag, not about the clinic's furniture.
- What should I ask before booking NAD+ IV therapy near me?
- Four things, in this order. Which pharmacy or outsourcing facility compounded the preparation. Whether the starting material was pharmaceutical grade rather than food grade. Whether the certificate of analysis for that material reports a bacterial endotoxins result, not only identity and purity. And what the lot number is. A provider who can answer all four has a supply chain it understands. A provider who treats the questions as unusual has told you something as well.
- Why does the grade of the material matter to a patient?
- Because FDA has documented harm arising from exactly that gap. The agency stated it was aware of compounders using food-grade nicotinamide adenine dinucleotide sold by repackagers to make intravenous products, that food-grade ingredients are not suitable for compounding sterile drugs without appropriate processing because of the risk of contamination with microbes and endotoxins, and that it had received adverse event reports of severe chills, shaking, vomiting and fatigue, some requiring medical treatment, consistent with excessive levels of endotoxins. Those reports followed administered products.
- How is a NAD+ injection near me priced compared to a vial?
- They are priced as different things, which is why this page carries no comparison figure. Clinics charge per session and commonly sell packages or memberships, and a session price bundles the preparation, the consumables, the room and the clinician. Price lists rarely state how much material is in the bag, so converting a session price into a cost per 100 mg cannot be done honestly from published information. The vial arithmetic that is checkable is set out on our price page.
- Do clinics have evidence that NAD+ infusions work?
- The biochemistry of NAD+ is settled and the clinical case is not, and those two things are routinely presented together. The published human record is thin: the most directly relevant study is a small uncontrolled pharmacokinetic pilot that tracked plasma and urine metabolites during and after a six-hour infusion, which describes where infused material goes rather than showing that anything improves. Clinics market infusions for a range of conditions well ahead of that evidence. This site reports the marketing and adopts none of it.
Limitations of the evidence
No clinic, chain or location is named on this page, and none is recommended. We have not visited a provider, obtained a compounding record, seen a certificate of analysis for any clinic preparation, or verified how any individual practice sources its material, so everything here describes what a reader can ask rather than what we found. No clinic price or price range appears, because we could not source published figures that resolved to checkable numbers and an invented range would be worse than an omission on a page about verification. Provider licensing and the rules governing administration vary by state and are outside our scope. The clinical uses clinics advertise are reported as marketing, not adopted as claims. NAD+ has no marketing authorisation as an injectable drug in the United States, the published human data are thin, and nothing here describes or implies human use.
References
Citations are annotated with an evidence tier reflecting study design and replication. See Methodology for criteria.
- 1.U.S. Food and Drug Administration · FDA reminds compounders to use ingredients suitable for sterile compounding · 2024Validated
- 2.U.S. Food and Drug Administration · Compounding and the FDA: Questions and Answers · 2025Validated
- 3.U.S. Food and Drug Administration · Registered Outsourcing Facilities · 2026Validated
- 4.Grant R, Berg J, Mestayer R, Braidy N, Bennett J, Broom S, Watson J · A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD · Frontiers in Aging Neuroscience · 2019PMID 31572171DOI 10.3389/fnagi.2019.00257Validated
- 5.Covarrubias AJ, Perrone R, Grozio A, Verdin E · NAD+ metabolism and its roles in cellular processes during ageing · Nature Reviews Molecular Cell Biology · 2021PMID 33353981DOI 10.1038/s41580-020-00313-xPreclinical